Literature DB >> 7237365

Cancer following medical irradiation.

J D Boice.   

Abstract

Several generalizations about radiation carcinogenesis can be made: 1) a single exposure is sufficient to elevate cancer incidence many years later: 2) radiation-induced cancer cannot be distinguished from naturally occurring cancer, i.e., there is not unique radiogenic cancer; 3) all cancers appear to be increased after irradiation with the exception of chronic lymphocytic leukemia, and possibly Hodgkin's disease, cervical cancer, and a few others; 4) the breast, thyroid, and bone marrow appear especially radiosensitive; 5) leukemia is the most prominent radiogenic tumor and shows a wave-like pattern of excess incidence over time, and the excess begins within two to four years, peaks about six to eight years, and decreases to normal levels about 25 years later; 6) solid tumors have a minimum latent period of about ten years, and for several cancers, the temporal pattern of incidence appears to follow the natural incidence, i.e., the cancers do not occur before the ages normally associated with increased incidence, implying that age-dependent factors influence the expression of disease; 7) age at exposure is perhaps the most important host factor influencing subsequent cancer risk; 8) the percentage increase in cancer incidence per rad is not the same for all cancers, i.e., some cancer of high natural incidence, e.g., colon, have low "relative risks" and some cancers of low natural incidence, e.g., thyroid, have high "relative risks;" 9) dose-effect curves are often linear, but curvilinearity is also observed and is possibly associated with the need for "two ionizing events" for transformation to occur at low doses, the influence of cell sterilization at moderate doses, the likelihood of "wasted" dose at high doses, and/or the influence of factors that effect the expression of disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7237365     DOI: 10.1002/1097-0142(19810301)47:5+<1081::aid-cncr2820471305>3.0.co;2-3

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  18 in total

1.  Second primary cancer following adjuvant chemotherapy, radiotherapy and endocrine therapy for breast cancer: a nationwide survey on 47,005 Japanese patients who underwent mastectomy from 1963-1982.

Authors:  Z Iwasa; D Jinnai; H Koyama; N Sasano
Journal:  Jpn J Surg       Date:  1986-07

Review 2.  An approach to repair of radiation necrosis of chest wall and mammary gland.

Authors:  W Sando; M J Jurkiewicz
Journal:  World J Surg       Date:  1986-04       Impact factor: 3.352

Review 3.  Fetal outcome after maternal radiation treatment of supradiaphragmatic Hodgkin's disease.

Authors:  E Friedman; G W Jones
Journal:  CMAJ       Date:  1993-11-01       Impact factor: 8.262

4.  Targeting progress in health.

Authors:  J M McGinnis
Journal:  Public Health Rep       Date:  1982 Jul-Aug       Impact factor: 2.792

Review 5.  The iatrogenic leukaemias induced by radio- and/or chemotherapy.

Authors:  Y Najean
Journal:  Med Oncol Tumor Pharmacother       Date:  1987

6.  Radiation-induced meningiomas: a shadow in the success story of childhood leukemia.

Authors:  Joanna Banerjee; Eija Pääkkö; Marika Harila; Riitta Herva; Juho Tuominen; Antero Koivula; Marjatta Lanning; Arja Harila-Saari
Journal:  Neuro Oncol       Date:  2009-01-29       Impact factor: 12.300

Review 7.  Growth hormone therapy and leukaemia.

Authors:  N Stahnke; H J Zeisel
Journal:  Eur J Pediatr       Date:  1989-06       Impact factor: 3.183

8.  Familial breast cancer: an investigation into the outcome of treatment for early stage disease.

Authors:  D Eccles; P Simmonds; J Goddard; M Coultas; S Hodgson; F Lalloo; G Evans; N Haites
Journal:  Fam Cancer       Date:  2001       Impact factor: 2.375

Review 9.  Radiation dose from initial trauma assessment and resuscitation: review of the literature.

Authors:  Catherine M Hui; John H MacGregor; Homer C Tien; John B Kortbeek
Journal:  Can J Surg       Date:  2009-04       Impact factor: 2.089

10.  Inflammatory bowel disease and leukemia. A report of seven cases of leukemia in ulcerative colitis and Crohn's disease and review of the literature.

Authors:  S H Mir Madjlessi; R G Farmer; J K Weick
Journal:  Dig Dis Sci       Date:  1986-10       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.